Key Takeaways Innovative product launches and biologics delivery advancements position BD to benefit from rising chronic disease trends and drive sustained revenue growth. Business transformation, operational efficiency gains, and emerging market expansion are set to enhance margins, cash flow stability, and global market diversification.Read more
